Among the 17 immunomodulatory proteins analyzed, three were significantly elevated in the patients with PAD who experienced 2-year MACE compared to those who did not: galectin-1, alpha-1-microglobulin, and galectin-9 (Table 2). The gene discussed is LGALS9; the disease is peripheral arterial disease.